SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Campos EI,Chin MY,Kuo WH,Li G. 2004. Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 61: 25972613.
  • Castelo-Branco G,Wagner J,Rodriguez FJ,Kele J,Sousa K,Rawal N,Pasolli HA,Fuchs E,Kitajewski J,Arenas E. 2003. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A 100: 1274712752.
  • Castro DS,Hermanson E,Joseph B,Wallen A,Aarnisalo P,Heller A,Perlmann T. 2001. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J Biol Chem 276: 4327743284.
  • Chen G,Shukeir N,Potti A,Sircar K,Aprikian A,Goltzman D,Rabbani SA. 2004. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 13451356.
  • Coats S,Flanagan WM,Nourse J,Roberts JM. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877880.
  • Feng X,Hara Y,Riabowol K. 2002. Different HATS of the ING1 gene family. Trends Cell Biol 12: 532538.
  • Garkavtsev I,Kozin SV,Chernova O,Xu L,Winkler F,Brown E,Barnett GH,Jain RK. 2004. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328332.
  • Gunduz M,Nagatsuka H,Demircan K,Gunduz E,Cengiz B,Ouchida M,Tsujigiwa H,Yamachika E,Fukushima K,Beder L,Hirohata S,Ninomiya Y,Nishizaki K,Shimizu K,Nagai N. 2005. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356: 109117.
  • Howe LR,Subbaramaiah K,Chung WJ,Dannenberg AJ,Brown AM. 1999. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 59: 15721577.
  • Hulit J,Lee RJ,Li Z,Wang C,Katiyar S,Yang J,Quong AA,Wu K,Albanese C,Russell R,Di Vizio D,Koff A,Thummala S,Zhang H,Harrell J,Sun H,Muller WJ,Inghirami G,Lisanti MP,Pestell RG. 2006. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/{beta}-catenin signaling. Cancer Res 66: 85298541.
  • Kim S,Chin K,Gray JW,Bishop JM. 2004. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci U S A 101: 1625116256.
  • Möbius C,Stein HJ,Spiess C,Becker I,Feith M,Theisen J,Gais P,Jutting U,Siewert JR. 2005. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol 31: 755759.
  • Nagashima M,Shiseki M,Miura K,Hagiwara K,Linke SP,Pedeux R,Wang XW,Yokota J,Riabowol K,Harris CC. 2001. DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci U S A 98: 96719676.
  • Nagashima M,Shiseki M,Pedeux RM,Okamura S,Kitahama-Shiseki M,Miura K,Yokota J,Harris CC. 2003. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 22: 343350.
  • Shiseki M,Nagashima M,Pedeux RM,Kitahama-Shiseki M,Miura K,Okamura S,Onogi H,Higashimoto Y,Appella E,Yokota J,Harris CC. 2003. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 63: 23732378.
  • Tzankov A,Heiss S,Ebner S,Sterlacci W,Schaefer G,Augustin F,Fiegl M,Dirnhofer S. 2007. Angiogenesis in nodal B cell lymphomas: a high throughput study. J Clin Pathol 60: 476482.
  • Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323330.
  • Wong SC,Lo SF,Lee KC,Yam JW,Chan JK,Wendy Hsiao WL. 2002. Expression of frizzled-related protein and Wnt-signaling molecules in invasive human breast tumours. J Pathol 196: 145153.
  • Zhang X,Xu LS,Wang ZQ,Wang KS,Li N,Cheng ZH,Huang SZ,Wei DZ,Han ZG. 2004. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett 570: 712.